A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours
Clinical trial NCT05514132 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05514132
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2023-10-20
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.